Northern Trust’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,821
| Closed | -$24K | – | 4871 |
|
|
2022
Q1 | $24K | Hold |
2,821
| – | – | ﹤0.01% | 4654 |
|
|
2021
Q4 | $32K | Hold |
2,821
| – | – | ﹤0.01% | 4662 |
|
|
2021
Q3 | $49K | Hold |
2,821
| – | – | ﹤0.01% | 4542 |
|
|
2021
Q2 | $52K | Hold |
2,821
| – | – | ﹤0.01% | 4492 |
|
|
2021
Q1 | $70K | Buy |
2,821
+2,021
| +253% | +$60.6K | ﹤0.01% | 4344 |
|
|
2020
Q4 | $16K | Buy |
800
+290
| +57% | +$5.68K | ﹤0.01% | 4331 |
|
|
2020
Q3 | $18K | Buy |
+510
| New | +$18.9K | ﹤0.01% | 4230 |
|
|
2020
Q1 | – | Sell |
-20
| Closed | -$3K | – | 4342 |
|
|
2019
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 4243 |
|
|
2019
Q3 | $8K | Hold |
20
| – | – | ﹤0.01% | 4202 |
|
|
2019
Q2 | $11K | Hold |
20
| – | – | ﹤0.01% | 4203 |
|
|
2019
Q1 | $23K | Hold |
20
| – | – | ﹤0.01% | 4120 |
|
|
2018
Q4 | $23K | Buy |
+20
| New | +$29K | ﹤0.01% | 4139 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | -$30K | – | 4389 |
|
|
2018
Q1 | $30K | Hold |
3
| – | – | ﹤0.01% | 4139 |
|
|
2017
Q4 | $47K | Hold |
3
| – | – | ﹤0.01% | 4082 |
|
|
2017
Q3 | $86K | Hold |
3
| – | – | ﹤0.01% | 3985 |
|
|
2017
Q2 | $161K | Sell |
3
-15
| -83% | -$819K | ﹤0.01% | 3867 |
|
|
2017
Q1 | $1.38M | Hold |
18
| – | – | ﹤0.01% | 3241 |
|
|
2016
Q4 | $1.44M | Hold |
18
| – | – | ﹤0.01% | 3242 |
|
|
2016
Q3 | $2.35M | Hold |
18
| – | – | ﹤0.01% | 2996 |
|
|
2016
Q2 | $1.98M | Buy |
18
+3
| +20% | +$353K | ﹤0.01% | 3038 |
|
|
2016
Q1 | $1.97M | Hold |
15
| – | – | ﹤0.01% | 2996 |
|
|
2015
Q4 | $2M | Buy |
15
+1
| +7% | +$149K | ﹤0.01% | 3063 |
|
|
2015
Q3 | $2.34M | Buy |
14
+11
| +367% | +$2.57M | ﹤0.01% | 2953 |
|
|
2015
Q2 | $932K | Buy |
+3
| New | +$793K | ﹤0.01% | 3369 |
|
Other funds holding NVIV
TRCT
IA
Northern Trust's NVIV Position: Q2 2022 in Review
Northern Trust sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2022, closing a stake of 2,821 shares — an estimated $24K sold.
Northern Trust first reported a position in NVIV in Q2 2015 and held it in 24 quarters. The position peaked at $2.35M in Q3 2016. 13 funds tracked by Wall St. Rank hold NVIV as of Q2 2022.
- Northern Trust reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2022 after selling out during the quarter.
- Northern Trust sold 2,821 InVivo Therapeutics Holdings Corp shares in Q2 2022, an estimated $24K.
- Northern Trust first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 24 quarters.
- Northern Trust's InVivo Therapeutics Holdings Corp position peaked at $2.35M in Q3 2016.
- 13 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2022.
Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.